Down-regulation of ERAP1 mRNA expression in non-small cell lung cancer

被引：0
|
作者：
Marta Wagner
Maciej Sobczyński
Monika Jasek
Konrad Pawełczyk
Irena Porębska
Piotr Kuśnierczyk
Andrzej Wiśniewski
机构：
[1] Polish Academy of Sciences,Laboratory of Genetics and Epigenetics of Human Diseases, Hirszfeld Institute of Immunology and Experimental Therapy
[2] Nencki Institute of Experimental Biology of the Polish Academy of Sciences,Laboratory of Molecular Neurobiology
[3] Department of Thoracic Surgery,Department of Pulmonology and Lung Oncology
[4] Lower Silesian Centre of Oncology,Laboratory of Immunogenetics and Tissue Immunology, Hirszfeld Institute of Immunology and Experimental Therapy
[5] Pulmonology and Haematology,undefined
[6] Wrocław Medical University,undefined
[7] Polish Academy of Sciences,undefined
来源：
BMC Cancer | / 23卷
关键词：
Non-small cell lung cancer; mRNA expression; rs26653; eQTL; Genetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer
    Karetsi, Eleni
    Ioannou, Maria G.
    Kerenidi, Theodora
    Minas, Markos
    Molyvdas, Paschalis A.
    Gourgoulianis, Konstantinos I.
    Paraskeva, Efrosyni
    CLINICS, 2012, 67 (12) : 1373 - 1378
  • [22] The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer
    Konishi, J
    Toyooka, S
    Aoe, M
    Omura, Y
    Washio, K
    Tsukuda, K
    Shimizu, N
    ONCOLOGY REPORTS, 2004, 11 (05) : 1063 - 1067
  • [23] Role of tesmin expression in non-small cell lung cancer
    Grzegrzolka, Jedrzej
    Olbromski, Mateusz
    Gomulkiewicz, Agnieszka
    Piotrowska, Aleksandra
    Glatzel-Plucinska, Natalia
    Ratajczak, Katarzyna
    Sputa-Grzegrzolka, Patrycja
    Rzechonek, Adam
    Werynska, Bozena
    Podhorska-Okolow, Marzena
    Dziegiel, Piotr
    ONCOLOGY LETTERS, 2021, 21 (01)
  • [24] Role of AXL expression in non-small cell lung cancer
    Qu, Xiaohan
    Liu, Jinlu
    Zhong, Xinwen
    Li, Xi
    Zhang, Qigang
    ONCOLOGY LETTERS, 2016, 12 (06) : 5085 - 5091
  • [25] Expression and clinical contribution of MRGD mRNA in non-small cell lung cancers
    Li, Zuyun
    Xie, You
    Zhong, Tengfei
    Zhang, Xiuling
    Dang, Yiwu
    Gan, Tingqing
    Chen, Gang
    JOURNAL OF BUON, 2015, 20 (04): : 1101 - 1106
  • [26] c-Myc down-regulation is involved in proteasome inhibitor-mediated enhancement of radiotherapeutic efficacy in non-small cell lung cancer
    Jung, Joohee
    Kim, Eun-Jin
    Chung, Hye Kyung
    Park, Heon Joo
    Jeong, Seong-Yun
    Choi, Eun Kyung
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (02) : 385 - 390
  • [27] Down-regulation of long noncoding RNA RP11-713B9.1 contributes to the cell viability in non-small cell lung cancer (NSCLC)
    Cai, Jun
    Wang, Xuan
    Huang, Hu
    Wang, Meng
    Zhang, Zhihong
    Hu, Yan
    Yu, Shihua
    Yang, Yonghua
    Yang, Jiyuan
    MOLECULAR MEDICINE REPORTS, 2017, 16 (03) : 3694 - 3700
  • [28] HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells
    Ko, Jen-Chung
    Chen, Huang-Jen
    Huang, Yu-Ching
    Tseng, Sheng-Chieh
    Weng, Shao-Hsing
    Wo, Ting-Yu
    Huang, Yi-Jhen
    Chiu, Hsien-Chun
    Tsai, Min-Shao
    Chiou, Robin Y. Y.
    Lin, Yun-Wei
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2012, 64 (03) : 415 - 424
  • [29] The Diagnostic Value of Circulating Stanniocalcin-1 mRNA in Non-Small Cell Lung Cancer
    Du, Yu-Zhen
    Gu, Xiao-Hua
    Li, Li
    Gao, Feng
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (07) : 836 - 840
  • [30] AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer
    Al-Khafaji, Ahmed S. K.
    Marcus, Michael W.
    Davies, Michael P. A.
    Risk, Janet M.
    Shaw, Richard J.
    Field, John K.
    Liloglou, Triantafillos
    ONCOLOGY LETTERS, 2017, 13 (06) : 4463 - 4468
12345